Cyclooxygenase-2 (COX-2) mediates arsenite inhibition of UVB-induced cellular apoptosis in mouse epidermal CL41 cells

Current Cancer Drug Targets

Volumn 12, Issue 6, 2012, Pages 607-616

  Zuo, Z ^a,b   Ouyang, W ^a   Li, J ^a   Costa, M ^a   Huang, C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Apoptosis; Arsenite; COX 2; NF B; UVB

Indexed keywords

ARSENIC TRIOXIDE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BASAL CELL; CELL DEATH; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; ARSENITES; CARCINOGENS, ENVIRONMENTAL; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; EPIDERMIS; GENES, REPORTER; MICE; NEOPLASMS, RADIATION-INDUCED; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; RNA INTERFERENCE; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; ULTRAVIOLET RAYS;

EID: 84862599541     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800912801784802     Document Type: Article

References (63)

1. Ball, P. Arsenic-free water still a pipedream. Nature 2005, 436, 313.
2. Nriagu, J.O. Environmental Chemistry of Arsenic, Dekker, New York. 2002.
3. Chen, C. J.; Wang, C. J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990, 50, 5470-5474.
4. Fawell, J. Physiological factors and environmental carcinogenesis. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Hum. Exp. Toxicol. 1995, 14, 464-465.
5. Cabrera, H. N.; Gomez, M. L. Skin cancer induced by arsenic in the water. J. Cutan. Med. Surg. 2003, 7, 106-111.
6. El Ghissassi, F.; Baan, R.; Straif, K.; Grosse, Y.; Secretan, B.; Bouvard, V.; Benbrahim-Tallaa, L.; Guha, N.; Freeman, C.; Galichet, L.; Cogliano, V. A review of human carcinogens--part D: radiation. Lancet. Oncol. 2009, 10, 751-752.
7. Longstreth, J.; de Gruijl, F. R.; Kripke, M. L.; Abseck, S.; Arnold, F.; Slaper, H. I.; Velders, G.; Takizawa, Y.; van der Leun, J. C. Health risks. J. Photochem. Photobiol. B 1998, 46, 20-39.
8. Meghaug, I.; Olseth, J. A.; Reuder, J. UV radiation and skin cancer in Norway. J. Photochem. Photobiol. B 2009, 96, 232-241.
9. Burns, F. J.; Uddin, A. N.; Wu, F.; Nadas, A.; Rossman, T. G. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ. Health Perspect. 2004, 112, 599-603.
10. Ouyang, W.; Zhang, D.; Ma, Q.; Li, J.; Huang, C. Cyclooxygenase- 2 induction by arsenite through the IKKbeta/NFkappaB pathway exerts an antiapoptotic effect in mouse epidermal Cl41 cells. Environ. Health Perspect. 2007, 115, 513-518.
11. Smith, W. L.; Garavito, R. M.; DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 1996, 271, 33157-33160.
12. Matsuzuka, T.; Miller, K.; Pickel, L.; Doi, C.; Ayuzawa, R.; Tamura, M. The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines. Mol. Cell Biochem. 2009, 320, 163-171.
13. Xu, K.; Chang, C. M.; Gao, H.; Shu, H. K. Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta. Oncogene 2009, 28, 1410-1420.
14. Tiano, H. F.; Loftin, C. D.; Akunda, J.; Lee, C. A.; Spalding, J.; Sessoms, A.; Dunson, D. B.; Rogan, E. G.; Morham, S. G.; Smart, R. C.; Langenbach, R. Deficiency of either cyclooxygenase (COX)- 1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 2002, 62, 3395-3401.
15. Fischer, S. M.; Lo, H. H.; Gordon, G. B.; Seibert, K.; Kelloff, G.; Lubet, R. A.; Conti, C. J. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog. 1999, 25, 231-240.
16. Ding, J.; Li, J.; Xue, C.; Wu, K.; Ouyang, W.; Zhang, D.; Yan, Y.; Huang, C. Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells. J. Biol. Chem. 2006, 281, 24405-24413.
17. Samaha, H. S.; Hamid, R.; ElBayoumy, K.; Rao, C. V.; Reddy, B. S. The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4- phenylenebis(methylene) selenocyanate. Cancer Epidem. Biomar. 1997, 6, 699-704.
18. Tsujii, M.; DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83, 493-501.
19. Ding, J.; Wu, K.; Zhang, D.; Luo, W.; Li, J.; Ouyang, W.; Song, L.; Huang, C. Activation of both nuclear factor of activated T cells and inhibitor of nuclear factor-kappa B kinase beta-subunit-/nuclear factor-kappa B is critical for cyclooxygenase-2 induction by benzo[a]pyrene in human bronchial epithelial cells. Cancer Sci. 2007, 98, 1323-1329.
20. Huang, C.; Zhang, D.; Li, J.; Tong, Q.; Stoner, G. D. (2007). Differential inhibition of UV-induced activation of NF kappa B and AP-1 by extracts from black raspberries, strawberries, and blueberries. Nutr. Cancer 2007, 58, 205-212.
21. Huang, C.; Ma, W. Y.; Li, J.; Dong, Z. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res. 1999, 59, 3053-3058.
22. Ouyang, W.; Ma, Q.; Li, J.; Zhang, D.; Liu, Z. G.; Rustgi, A. K.; Huang, C. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arseniteinduced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 2005, 65, 9287-9293.
23. Huang, C.; Huang, Y.; Li, J.; Hu, W.; Aziz, R.; Tang, M. S.; Sun, N.; Cassady, J.; Stoner, G. D. Inhibition of benzo(a)pyrene diolepoxide- induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res. 2002, 62, 6857-6863.
24. Guo, W.; Yang, Z.; Xia, Q.; Liu, J.; Yu, Y.; Li, J.; Zuo, Z.; Zhang, D.; Li, X.; Shi, X.; Huang, C. Arsenite stabilizes HIF-1α protein through p85α-mediated up-regulation of inducible Hsp70 protein expression. Cell Mol Life Sci. 2011, 68, 475-488.
25. Mammone, T.; Gan, D.; Collins, D.; Lockshin, R. A.; Marenus, K.; Maes, D. Successful separation of apoptosis and necrosis pathways in HaCaT keratinocyte cells induced by UVB irradiation. Cell Biol. Toxicol. 2000, 16, 293-302.
26. Liu, X. J.; Shi, S. T.; Ye, J. L.; Liu, L. Q.; Sun, M.; Wang, C. B. Effect of polypeptide from Chlamys farreri on UVB-induced ROS/NF-kappa B/COX-2 activation and apoptosis in HaCaT cells. J. Photochem. Photobiol. B 2009, 96, 109-116.
27. Pauloin, T.; Dutot, M.; Joly, F.; Warnet, J. M.; Rat, P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol. Vision 2009, 15, 577-583.
28. Kapahi, P.; Takahashi, T.; Natoli, G.; Adams, S. R.; Chen, Y.; Tsien, R. Y.; Karin, M. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of I kappa B kinase. J. Biol. Chem. 2000. 275, 36062-36066.
29. Song, L.; Li, J. X.; Zhang, D. Y.; Liu, Z. G.; Ye, J. P.; Zhan, Q. M.; Huang, C. S. IKK beta programs to turn on the GADD45 alpha- MKK4-JNK apoptotic cascade specifically via p50 NF-kappa B in arsenite response. J. Cell Biol. 2006, 175, 607-617.
30. Ouyang, W. M.; Luo, W. J.; Zhang, D. Y.; Jian, J. L.; Ma, Q.; Li, J. X.; Huang, C. S. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation. Environ. Health Persp. 2008, 116, 1-6.
31. Pi, J.; He, Y.; Bortner, C.; Huang, J.; Liu, J.; Zhou, T.; Qu, W.; North, S. L.; Kasprzak, K. S.; Diwan, B. A.; Chignell, C. F.; Waalkes, M. P. Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int. J. Cancer 2005, 116, 20-26.
32. Buckman, S.Y.; Gresham, A.; Hale, P.; Hruza, G.; Anast, J.; Masferrer, J.; Pentland, A.P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19, 723-729.
33. Shi, B.; Isseroff, R. R. Arsenite pre-conditioning reduces UVBinduced apoptosis in corneal epithelial cells through the antiapoptotic activity of 27 kDa heat shock protein (HSP27). J. Cell. Physiol. 2006, 206, 301-308.
34. Kundu, J. K.; Chang, E. J.; Fujii, H.; Sun, B.; Surh, Y. J. Oligonol inhibits UVB-induced COX-2 expression in HR-1 hairless mouse skin--AP-1 and C/EBP as potential upstream targets. Photochem. Photobiol. 2008, 84, 399-406.
35. Tang, X.; Kim, A. L.; Kopelovich, L.; Bickers, D. R.; Athar, M. Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet Binduced photocarcinogenesis in SKH-1 hairless mice. Photochem. Photobiol. 2008, 84, 522-527.
36. Cho, J. W.; Park, K.; Kweon, G. R.; Jang, B. C.; Baek, W. K.; Suh, M. H.; Kim, C. W.; Lee, K. S.; Suh, S. I. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp. Mol. Med. 2005, 37, 186- 192.
37. Ouyang, W.; Ma, Q.; Li, J.; Zhang, D.; Ding, J.; Huang, Y.; Xing, M. M.; Huang, C. Benzo[a]pyrene diol-epoxide (B[a]PDE) upregulates COX-2 expression through MAPKs/AP-1 and IKKbeta/NF-kappaB in mouse epidermal Cl41 cells. Mol. Carcinog. 2007, 46, 32-41.
38. Song, L.; Li, J. X.; Hu, M. R.; Huang, C. S. Both IKK alpha and IKK beta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappa B activity-independent manner. Exp. Cell Res. 2008, 314, 2187-2198.
39. Chan, P.C.; Huff, J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ. Carcinog. Ecotoxicol. Rev. 1997, C15, 83-122.
40. Gomez-Caminero, A.; Howe, P.; Hughes, M.; Kenyon, E.; Lewis, D. R.; Moore, M.; Ng, J.; Aitio, A.; Becking, G. Arsenic and Arsenic Compounds. World Health Organization, Geneva. 2001.
41. Tseng, W. P. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 1977, 19, 109-119.
42. Pi, J.; Yamauchi, H.; Kumagai, Y.; Sun, G.; Yoshida, T.; Aikawa, H.; Hopenhayn-Rich, C.; Shimojo, N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 2002, 110, 331-336.
43. Ng, J. C. Bioavailability and Toxicology of Arsenic in the Environment. Ph. D. Thesis. University of Queensland, Australia. 1999.
44. Simeonova, P. P.; Wang, S.; Toriuma, W.; Kommineni, V.; Matheson, J.; Unimye, N.; Kayama, F.; Harki, D.; Ding, M.; Vallyathan, V.; Luster, M. I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with activating protein-1 transactivation. Cancer Res. 2000, 60, 3445- 3453.
45. Straub, A. C.; Clark, K. A.; Ross, M. A.; Chandra, A. G.; Li S.; Gao, X.; Pagano, P. J.; Stolz, D. B.; Barchowsky, A. Arsenicstimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. Clin. Invest. 2008, 118, 3980-3989.
46. Andrew, A. S.; Karagas, M. R.; Hamilton, J. W. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int. J. Cancer 2003, 104, 263-268.
47. Hartwig, A.; Groblinghoff, U. D.; Beyersmann, D.; Natarajan, A. T.; Filon, R.; Mullenders, L. H. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997, 18, 399-405.
48. Danaee, H.; Nelson, H. H.; Liber, H.; Little, J. B.; Kelsey, K. T. Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis 2004, 19, 143-148.
49. Sykora, P.; Snow, E. T. Modulation of DNA polymerase betadependent base excision repair in cultured human cells after low dose exposure to arsenite. Toxicol. Appl. Pharmacol. 2008, 228, 385-394.
50. Ding, W.; Liu, W.; Cooper, K. L.; Qin, X. J.; de Souza Bergo, P. L.; Hudson, L. G.; Liu, K. J. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 2009, 284, 6809-6817.
51. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100, 57-70.
52. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst. 1998, 90, 1609-1620.
53. Xu, L.; Zhang, L.; Yi, Y.; Kang, H. K.; Datta, S. K. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat. Med. 2004, 10, 411-415.
54. Dannenberg, A. J.; Lippman, S. M.; Mann, J. R.; Subbaramaiah, K.; DuBois, R. N. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J. Clin. Oncol. 2005, 23, 254-266.
55. Tjiu, J. W.; Liao, Y. H.; Lin, S. J.; Huang, Y. L.; Tsai, W. L.; Chu, C. Y.; Kuo, M. L.; Jee, S. H. Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis. J. Invest. Dermatol. 2006, 126, 1143-1151.
56. Yan, Y.; Li, J.; Ouyang, W.; Ma, Q.; Hu, Y.; Zhang, D.; Ding, J.; Qu, Q.; Subbaramaiah, K.; Huang, C. NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells. J. Cell Sci. 2006, 119, 2985-2994.
57. Huang, C.; Bode, A. M.; Chen, N. Y.; Ma, W. Y.; Li, J.; Nomura, M.; Dong, Z. Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenate. Anticancer Res. 2001, 21, 261-267.
58. Zuo, Z.; Cai, T.; Li, J.; Zhang, D.; Yu, Y.; Huang, C. Hexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathway. Environ. Health Perspect. 2012, 120, 547-553.
59. Cai, T.; Li, X.; Ding, J.; Luo, W.; Li, J.; Huang, C. A cross-talk between NFAT and NF-_B pathways is crucial for nickel-induced COX-2 expression in Beas-2B cells. Curr. Cancer Drug Targets. 2011, 11, 548-559.
60. Chai, C. Y.; Huang, Y. C.; Hung, W. C.; Kang, W. Y.; Chen, W. T. Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells. Mutagenesis 2007, 22, 403-408.
61. Kitchin, K. T.; Conolly, R. Arsenic-induced carcinogenesisoxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem. Res. Toxicol. 2010, 23 (2), 327-335.
62. Ma, Y.; Wang, J. Z.; Liu, L. X.; Zhu, H. Q.; Chen, X. N.; Pan, S. H.; Sun, X. Y.; Jiang, H. C. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-kappa B. Cancer Lett. 2011, 301, 75-84.
63. Flockhart, R. J.; Diffey, B. L.; Farr, P. M.; Lloyd, J.; Reynolds, N. J. NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. FASEB J. 2008, 22, 4218-4227.